Two-and 13-week inhalation toxicities of indium-tin oxide and indium oxide in rats

Journal of Occupational Health

Volumn 53, Issue 2, 2011, Pages 51-63

  Nagano, Kasuke ^a   Gotoh, Kaoru ^a   Kasai, Tatsuya ^a   Aiso, Shigetoshi ^a   Nishizawa, Tomoshi ^a   Ohnishi, Makoto ^a   Ikawa, Naoki ^a   Eitaki, Yoko ^a   Yamada, Kenichi ^a   Arito, Heihachiro ^a   Fukushima, Shoji ^a  

^a JAPAN INDUSTRIAL SAFETY AND HEALTH ASSOCIATION   (Japan)

Author keywords

Indium oxide; Indium tin oxide; Inhalation; Pulmonary toxicity; Rat

Indexed keywords

INDIUM; INDIUM OXIDE; INDIUM TIN OXIDE; TIN DERIVATIVE;

ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; EXPOSURE; FEMALE; FISCHER 344 RAT; INHALATIONAL DRUG ADMINISTRATION; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS PROTEINOSIS; LUNG FIBROSIS; MALE; PATHOLOGY; RAT; TIME;

ADMINISTRATION, INHALATION; ANIMALS; FEMALE; INDIUM; INHALATION EXPOSURE; MACROPHAGES, ALVEOLAR; MALE; PULMONARY ALVEOLAR PROTEINOSIS; PULMONARY FIBROSIS; RATS; RATS, INBRED F344; TIME FACTORS; TIN COMPOUNDS;

EID: 80051918402     PISSN: 13419145     EISSN: 13489585     Source Type: Journal    
DOI: 10.1539/joh.L10128     Document Type: Article

References (34)

1. Jorgenson JD, George MW. Mineral Commodity Profile-Indium. Open-File Report 2004-1300. US. Geological Survey, Reston, VA. [Online]. 2005 [cited 2010 Jun 16]; Available from: URL: http://pubs.usgs.gov/of/2004/1300/2004-1300.pdf
2. Homma T, Ueno T, Sekizawa K, Tanaka A, Hirata M. Interstitial pneumonia developed in a worker dealing with particles containing indium-tin oxide. J Occup Health 2003; 45: 137-9.
3. Cummings KJ, Donat WE, Ettensohn DB, Roggli VL, Ingram P, Kreiss K. Pulmonary alveolar proteinosis in workers at an indium processing facility. Am J Respir Crit Care Med 2010; 181: 458-64.
4. Chonan T, Taguchi O, Omae K. Interstitial pulmonary disorders in indium-processing workers. Eur Respir J 2007; 29: 317-24.
5. Hamaguchi T, Omae K, Takebayashi T, et al. Exposure to hardly soluble indium compounds in ITO production and recycling plants is a new risk for interstitial lung damage. Occup Environ Med 2008; 65: 51-5.
6. Nogami H, Shimoda T, Shoji S, Nishima S. Pulmonary disorders in indium-processing workers. J JPN Respir Soc 2008; 46: 60-4 (in Japanese).
7. Nakano M, Omae K, Tanaka A, et al. Causal relationship between indium compound inhalation and effects on the lungs. J Occup Health 2009; 51: 513-21.
8. Lison D, Laloy J, Corazzari I, et al. Sintered indiumtin-oxide (ITO) particles: a new pneumotoxic entity. Toxicol Sci 2009; 108: 472-81.
9. Tanaka A, Hirata M, Omura M, et al. Pulmonary toxicity of indium-tin oxide and indium phosphide after intratracheal instillations into the lung of hamsters. J Occup Health 2002; 44: 99-102.
10. Tanaka A, Hirata M, Homma T, Kiyohara Y. Chronic pulmonary toxicity study of indium-tin oxide and indium oxide following intratracheal instillations into the lungs of hamsters. J Occup Health 2010; 52: 14-22.
11. Blazka ME, Dixon D, Haskins E, Rosenthal GJ. Pulmonary toxicity to intratracheally administered indium trichloride in Fischer 344 rats. Fundam Appl Toxicol 1994; 22: 231-9.
12. 1 mice (Inhalation studies). NTP TR 499. Research Triangle Park (NC): U.S. Department of Health and Human Service, Public Health Service, National Institute of Health; 2001.
13. American Conference of Governmental Industrial Hygienists (ACGIH). Indium and compounds. In: Documentation of the threshold limit values (TLVs) and biological exposure indices (BEIs) [CD-ROM 2007]. Cincinnati (OH): ACGIH; 2001.
14. National Institute for Occupational Safety and Health (NIOSH). NIOSH pocket guide to chemical hazards- Indium. [Online]. 2005 [cited 2010 Jun 10]; Available from: URL: http://www.cdc.gov/niosh/npg/npgd0341. html
15. Japan Society for Occupational Health (JSOH). Documentation of OEL and BEI for indium and its compounds. San Ei Shi 2007; 49: 196-202 (in Japanese).
16. Organization for Economic Co-operation and Development (OECD). OECD principles on good laboratory practice. OECD series on principles of good laboratory practice and compliance monitoring No.1. ENV/MC/CHEM (98) 17. Paris (France): OECD; 1998.
17. Organization for Economic Co-operation and Development (OECD). OECD guideline for testing of chemicals. Repeated dose inhalation toxicity: 28-day or 14-day study. Adopted 12 May, 1981. Paris (France): OECD; 1981.
18. Organization for Economic Co-operation and Development (OECD). OECD guideline for testing of chemicals. Subchronic inhalation toxicity: 90-day study. Adopted 12 May, 1981. Paris (France): OECD; 1981.
19. National Research Council (NRC). Guide for the care and use of laboratory animals. Washington, DC: National Academies Press; 1996.
20. Shackelford C, Long G, Wolf J, Okerberg C, Herbert R. Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies. Toxicol Pathol 2002; 30: 93-6.
21. Aiso S, Arito H, Nishizawa T, Nagano K, Yamamoto S, Matsushima T. Thirteen-week inhalation toxicity of p-dichlorobenzene in mice and rats. J Occup Health 2005; 47: 249-60.
22. Kabe I, Omae K, Nakashima H, et al. In vitro solubility and in vivo toxicity of indium phosphide. J Occup Health 1996; 38: 6-12.
23. Dittmar TB, Fernando Q, Leavitt JA, McIntyre Jr LC. Surface concentrations of indium, phosphorus, and oxygen in indium phosphide single crystals after exposure to Gamble solution. Anal Chem 1992; 64: 2929-33.
24. Brain JD, Curran MA, Donaghey T, Molina RM. Biologic responses to nanomaterials depend on exposure, clearance, and material characteristics. Nanotoxicol 2009; 3: 174-80.
25. Suzuki Y, Matsushita H. Interaction of metal ions with phospholipid monolayer and their acute toxicity. Ind Health 1969; 7: 143-54.
26. Fan JCC, Goodenough JB. X-ray photoemission spectroscopy studies of Sn-doped indium-oxide films. J Appl Phys 1977; 48: 3524-31.
27. Morrow PE. Possible mechanisms to explain dust overloading of the lungs. Fundam Appl Toxicol 1988; 10: 369-84.
28. Rosen SH, Castleman B, Liebow AA, et al. Pulmonary alveolar proteinosis. The New England J Med 1958; 258: 1123-42.
29. Davidson JM, Macleod WM. Pulmonary alveolar proteinosis. Brit J Dis Chest 1969; 63: 13-28.
30. Gross P, de Treville RTP. Alveolar proteinosis. Its experimental production in rodents. Arch Path 1968; 86: 255-61.
31. Corrin B, King E. Pathogenesis of experimental pulmonary alveolar proteinosis. Thorax 1970; 25: 230-6.
32. Homma S, Miyamoto A, Sakamoto S, Kishi K, Motoi N, Yoshimura K. Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide. Eur Respir J 2005; 25: 200-4.
33. Leach LJ, Scott JK, Armstrong RD, Steadman LT, Maynard EA. The inhalation toxicity of indium sesquioxide in the rat. The University of Rochester Atomic Energy Project, Report No.UR-590. Rochester (NY): Univ of Rochester; 1961.
34. Miyaki K, Hosoda K, Hirata M, et al. Biological monitoring of indium by means of graphite furnace atomic absorption spectrophotometry in workers exposed to particles of indium compounds. J Occup Health 2003; 45: 228-30.